88 related articles for article (PubMed ID: 22094583)
1. Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation.
Xu D; Hu J; Xu S; De Bruyne E; Menu E; Van Camp B; Vanderkerken K; Van Valckenborgh E
Leukemia; 2012 Jun; 26(6):1402-5. PubMed ID: 22094583
[No Abstract] [Full Text] [Related]
2. Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.
Chiron D; Maïga S; Descamps G; Moreau P; Le Gouill S; Marionneau S; Ouiller T; Moreaux J; Klein B; Bataille R; Amiot M; Pellat-Deceunynck C
Blood Cells Mol Dis; 2012 Apr; 48(4):247-53. PubMed ID: 22341562
[TBL] [Abstract][Full Text] [Related]
3. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
[TBL] [Abstract][Full Text] [Related]
5. Delta-like 1-Lysine613 regulates notch signaling.
Zhang L; Widau RC; Herring BP; Gallagher PJ
Biochim Biophys Acta; 2011 Dec; 1813(12):2036-43. PubMed ID: 21985982
[TBL] [Abstract][Full Text] [Related]
6. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
7. Dll3 is expressed in developing hair cells in the mammalian cochlea.
Hartman BH; Hayashi T; Nelson BR; Bermingham-McDonogh O; Reh TA
Dev Dyn; 2007 Oct; 236(10):2875-83. PubMed ID: 17823936
[TBL] [Abstract][Full Text] [Related]
8. Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.
Xu S; Evans H; Buckle C; De Veirman K; Hu J; Xu D; Menu E; De Becker A; Vande Broek I; Leleu X; Camp BV; Croucher P; Vanderkerken K; Van Riet I
Leukemia; 2012 Dec; 26(12):2546-9. PubMed ID: 22652628
[No Abstract] [Full Text] [Related]
9. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
10. Effects of hepatocyte growth factor-mediated activation of Dll4-Notch-Hey2 signaling pathway.
Gao YF; Ha XQ; Lü TD; Han JP
Chin Med J (Engl); 2011 Jan; 124(1):127-31. PubMed ID: 21362320
[TBL] [Abstract][Full Text] [Related]
11. CD138 shedding in plasma cell myeloma.
Grigoriadis G; Whitehead S
Br J Haematol; 2010 Aug; 150(3):249. PubMed ID: 20433680
[No Abstract] [Full Text] [Related]
12. Quantitative Analysis of Delta-like 1 Membrane Dynamics Elucidates the Role of Contact Geometry on Notch Signaling.
Khait I; Orsher Y; Golan O; Binshtok U; Gordon-Bar N; Amir-Zilberstein L; Sprinzak D
Cell Rep; 2016 Jan; 14(2):225-33. PubMed ID: 26748704
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Notch ligand Dll1 in B16 melanoma cells leads to reduced tumor growth due to attenuated vascularization.
Zhang JP; Qin HY; Wang L; Liang L; Zhao XC; Cai WX; Wei YN; Wang CM; Han H
Cancer Lett; 2011 Oct; 309(2):220-7. PubMed ID: 21752535
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of pumpkin protein on expression of Notch signal in RPMI8226 myeloma cells].
Liu TB; Yang P; Xie JM; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1012-5. PubMed ID: 25130819
[TBL] [Abstract][Full Text] [Related]
15. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance.
Duncan AW; Rattis FM; DiMascio LN; Congdon KL; Pazianos G; Zhao C; Yoon K; Cook JM; Willert K; Gaiano N; Reya T
Nat Immunol; 2005 Mar; 6(3):314-22. PubMed ID: 15665828
[TBL] [Abstract][Full Text] [Related]
16. CD138+ cell separation affects cancer gene expression in human myeloma cell lines.
Sørrig R; Hermansen NE; Hother C; Gimsing P
Eur J Haematol; 2013 Aug; 91(2):187-8. PubMed ID: 23581887
[No Abstract] [Full Text] [Related]
17. Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model.
Van Valckenborgh E; Matsui W; Agarwal P; Lub S; Dehui X; De Bruyne E; Menu E; Empsen C; van Grunsven L; Agarwal J; Wang Q; Jernberg-Wiklund H; Vanderkerken K
Leukemia; 2012 Jun; 26(6):1436-9. PubMed ID: 22289925
[No Abstract] [Full Text] [Related]
18. Notch inhibition blocks multiple myeloma cell-induced osteoclast activation.
Schwarzer R; Kaiser M; Acikgoez O; Heider U; Mathas S; Preissner R; Sezer O; Doerken B; Jundt F
Leukemia; 2008 Dec; 22(12):2273-7. PubMed ID: 18528422
[No Abstract] [Full Text] [Related]
19. CD138
Shuai W; Li S
Blood; 2019 Sep; 134(11):906. PubMed ID: 31515228
[No Abstract] [Full Text] [Related]
20. Notch1 induces enhanced expression of Delta-like-1 in the U251MG glioma cell line.
Qian CF; Yan W; Zhang JX; Shi L; Qian J; Fu Z; Kang CS; Liu N; You YP
Int J Mol Med; 2009 Oct; 24(4):445-51. PubMed ID: 19724883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
